[1] Practice Committee of the American Society for Reproductive Medicine. Prevention of moderate and severe ovarian hyperstimulation syndrome: a guideline[J]. Fertil Steril, 2024, 121(2):230-245.
[2] 葛蓓蕾, 郑真真, 朱一萍, 等. 自发性卵巢过度刺激综合征68例临床分析[J]. 现代妇产科进展, 2022, 31(11):833-837.
[3] Maxwell K N, Cholst I N, Rosenwaks Z. The incidence of both serious and minor complications in young women undergoing oocyte donation[J]. Fertil Steril, 2008, 90(6):2165-2171.
[4] Royal College of Obstetricians and Gynaecologists. The Management of Ovarian Hyperstimulation Syndrome(Green-top Guideline No.5) [EB/OL]. 2016. https://www.rcog.org.uk/globalassets/documents/guidelines/green-top-guidelines/gtg_5_ohss.Pdf
[5] 王欣欣, 钱永红. 自发性卵巢过度刺激综合征合并卵巢破裂一例并文献复习[J]. 国际妇产科学杂志, 2021, 48(5):528-531.
[6] Kurioka H, Takahashi K, Kita N, et al. Hemorrhagic ovarian cyst without peritoneal bleeding in a patient with ovarian hyperstimulation syndrome: case report[J]. Chin Med J (Engl), 2005, 118(18):1577-1581.
[7] Stojnic J, Bila J, Tulic L, et al. Severe hemoperitoneum due to ovarian bleeding after transvaginal oocyte retrieval with surgical management: a retrospective analysis and comprehensive review of the literature[J]. Medicina (Kaunas), 2023, 59(2):307.
[8] Soares S R, Gómez R, Simón C, et al. Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome[J]. Hum Reprod Update, 2008, 14(4):321-333.
[9] Comba C, Ugurlucan F G, Bastu E, et al. Persistent ascites resolving with gonadotropin-releasing-hormone-agonist 18 months after hospitalization for severe ovarian hyperstimulation syndrome [J]. Arch Gynecol Obstet, 2014, 289(1): 223-225.
[10] 王晓宁, 刁红录, 张昌军. 羟乙基淀粉预防卵巢过度刺激综合征的应用进展[J]. 重庆医学, 2019, 48(6):1018-1020, 1024.
[11] 黄琪婷. 羟乙基淀粉治疗早发型中重度卵巢过度刺激综合征的临床研究[D]. 福州:福建中医药大学,2015.
[12] Abramov Y, Fatum M, Abrahamov D, et al. Hydroxyethylstarch versus human albumin for the treatment of severe ovarian hyperstimulation syndrome: a preliminary report[J]. Fertil Steril, 2001, 75(6):1228-1230.
[13] Yu Y T, Liu J, Hu B, et al. Expert consensus on the use of human serum albumin in critically ill patients[J]. Chin Med J (Engl), 2021, 134(14):1639-1654.